MARKET

HSIC

HSIC

Henry Schein
NASDAQ

Real-time Quotes | Nasdaq Last Sale

67.20
-0.79
-1.16%
After Hours: 67.20 0 0.00% 16:42 08/11 EDT
OPEN
68.26
PREV CLOSE
67.99
HIGH
69.17
LOW
66.75
VOLUME
1.47M
TURNOVER
--
52 WEEK HIGH
73.99
52 WEEK LOW
41.85
MARKET CAP
9.59B
P/E (TTM)
16.86
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average HSIC stock price target is 71.36 with a high estimate of 102.00 and a low estimate of 50.00.

EPS

HSIC News

More
Henry Schein (HSIC) Q2 2020 Earnings Call Transcript
Thank you, Regina, and my thanks to each of you for joining us to discuss Henry Schein's results for the second quarter of 2020. With me on the call today are Stanley Bergman, chairman of the board and chief executive officer at Henry Schein; and Steven Palad
Motley Fool · 6d ago
Henry Schein -2.4% despite beating Q2 earnings
For Q2, Henry Schein (HSIC -2.5%) reported Q2 revenue of $1.68B (-31.2% Y/Y), beating consensus by $300M. Drop in revenue was mainly due to the impact of p
seekingalpha · 6d ago
Henry Schein (HSIC) Q2 Earnings Top Estimates, Margins Dip
Henry Schein (HSIC) sees dismal segmental performance in Q2 due to disruptions resulting from the coronavirus pandemic.
Zacks · 08/04 14:30
Henry Schein (HSIC) Reports Break-Even Earnings for Q2
Henry Schein (HSIC) delivered earnings and revenue surprises of 100.00% and 19.98%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 12:25
Henry Schein Q2 Sales $1.68B Beat $1.38B Estimate
Henry Schein (NASDAQ:HSIC) reported quarterly sales of $1.68 billion which beat the analyst consensus estimate of $1.38 billion by 22.03 percent. This is a 31.21 percent decrease over sales of $2.45 billion the same
Benzinga · 08/04 11:28
Henry Schein Q2 Adj. EPS $0.00 vs $0.84 In Same Qtr. Last Year, Sales $1.68B Beat $1.38B Estimate
Henry Schein (NASDAQ:HSIC) reported quarterly sales of $1.68 billion which beat the analyst consensus estimate of $1.38 billion by 22.03 percent. This is a 31.21 percent decrease over sales of $2.45 billion the same
Benzinga · 08/04 11:24
Henry Schein Reports Second Quarter 2020 Financial Results
Henry Schein, Inc. reports second quarter 2020 financial results from continuing operations.
Business Wire · 08/04 11:00
Henry Schein Q2 2020 Earnings Preview
Seeking Alpha - Article · 08/03 16:21

Industry

Medical Equipment, Supplies & Distribution
-0.65%
Healthcare Equipment & Supplies
-0.72%

Hot Stocks

Symbol
Price
%Change

About HSIC

Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The Company provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.
More

Webull offers kinds of Henry Schein, Inc. stock information, including NASDAQ:HSIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HSIC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading HSIC stock methods without spending real money on the virtual paper trading platform.